Skip to main content
Premium Trial:

Request an Annual Quote

Now Everyone Wants to Do Drug Discovery

The Wall Street Journal runs an article profiling multimillionaire and melanoma patient Jay Tenenbaum and the company he founded, CollabRx, to get patients involved in helping develop therapeutics faster and for less money than the process currently takes. The projects that CollabRx takes on are called "virtual biotechs," according to the story, "because they aim to replicate many of the steps typically taken as part of a pharmaceutical or biotech company's search for a new drug."

 

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.